Calendar

pharmadog

Date TBD

COMPLETEDphase readoutNCT01942343: Akathisia in Post Operative Outpatients Surgery

Sponsor: University Hospital, Strasbourg, France. Phase: PHASE3. Conditions: Akathisia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07642843: CM336 for Active Sjogren's Syndrome Study

Sponsor: Keymed Biosciences Co.Ltd. Phase: PHASE1. Conditions: Primary Sjögren's Syndrome (pSS)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06967415: Comparison of Pain, Sensitisation, Function and Quality of Life According to Stenosis Degree in Chronic Neck Pain

Sponsor: Izmir Democracy University. Phase: NA. Conditions: Central Sensitisation, Cervical Spine Stenosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07054515: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Sponsor: Azafaros B.V.. Phase: PHASE3. Conditions: Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06924515: The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

Sponsor: Mingjian Ge. Phase: NA. Conditions: VATS, Lung Hernia

full page →ctgov ↗

RECRUITINGphase readoutNCT06159335: 18F-FLUC PET/MR in Patients With Brain Mets

Sponsor: University of Wisconsin, Madison. Phase: PHASE3. Conditions: Brain Metastasis, Radiation Therapy, Immunotherapy, Active

full page →ctgov ↗

COMPLETEDphase readoutNCT04197908: EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Acute Cholecystitis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07210125: Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Sponsor: Kelley-Ross & Associates, Inc.. Phase: PHASE4. Conditions: HIV

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07423325: Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans Epidermal Water Loss, Skin Surface Assessment, Sebum and Least-Reflection Factor.

Sponsor: NovoBliss Research Pvt Ltd. Phase: NA. Conditions: Dry and Sensitive Skin

full page →ctgov ↗

RECRUITINGphase readoutNCT05274425: A 24-week rPMS Study in Real-world Setting for Enerzair

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Asthma

full page →ctgov ↗

RECRUITINGphase readoutNCT05266976: Mode of Exercise and Bone Biomarkers in Older Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Aging, Musculoskeletal Diseases, Osteoporosis

full page →ctgov ↗

COMPLETEDphase readoutNCT06719076: IMPACT OF DIABETES HEALTHCARE PROGRAM ON GLYCEMIC CONTROL, SELF-EFFICACY AND DIABETES KNOWLEDGE AMONG TYPE-II DIABETICS IN ISLAMABAD PAKISTAN

Sponsor: Health Services Academy, Islamabad, Pakistan. Phase: NA. Conditions: HbA1c, Self-Efficacy, Diabetes Knowledge

full page →ctgov ↗

RECRUITINGphase readoutNCT07228117: GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Sponsor: Medtronic MiniMed, Inc.. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07485517: Deep Versus Moderate Neuromuscular Blocking

Sponsor: Menoufia University. Phase: NA. Conditions: Change in Serum Levels of the Estimated Inflammatory Cytokines, Total Dose of IO Fentanyl, PO Morphine, Surgeons' Rating, Pain Scores

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07373717: Consistency of Fluid Tolerance Evaluation Methods and Their Correlation With Clinical Outcomes in Patients With Shock

Sponsor: Southeast University, China. Phase: . Conditions: Shock

full page →ctgov ↗

COMPLETEDphase readoutNCT06695117: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Sponsor: Sanofi. Phase: PHASE1. Conditions: COVID-19 Immunization, Influenza Immunization

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04386317: Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT05245617: Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb

Sponsor: Orthofix s.r.l.. Phase: . Conditions: Deformity, Defect, Congenital, Trauma

full page →ctgov ↗

RECRUITINGphase readoutNCT06691217: Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Vascular Inflammation, ASCVD, ASCVD Management

full page →ctgov ↗

TERMINATEDphase readoutNCT04587440: Is the Dynamic of the Pelvic Bone Altered After a Total Hip Replacement ?

Sponsor: University Hospital, Brest. Phase: NA. Conditions: Coxarthrosis; Primary, Coxarthrosis; Secondary

full page →ctgov ↗

RECRUITINGphase readoutNCT07290140: Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Sponsor: Airiver Medical, Inc.. Phase: NA. Conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

full page →ctgov ↗

COMPLETEDphase readoutNCT05861089: Rest PETCO2 as a Predictor of Post-operative Complications

Sponsor: St. Anne's University Hospital Brno, Czech Republic. Phase: . Conditions: Post-Op Complication

full page →ctgov ↗

RECRUITINGphase readoutNCT06163989: Protecting the Eyes of Gamers With Lubricating Eyedrops

Sponsor: Aston University. Phase: NA. Conditions: Dry Eye Syndromes, Computer Vision Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07428889: Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

Sponsor: Shaklee Corporation. Phase: NA. Conditions: Healthy Adult

full page →ctgov ↗

RECRUITINGphase readoutNCT00801489: Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, de Novo Myelodysplastic Syndrome, High Risk Myelodysplastic Syndrome, Inv(16), Myelodysplastic Syndrome With Excess Blasts, t(16;16), t(8;21), Untreated Adult Acute Myeloid Leukemia

full page →ctgov ↗

COMPLETEDphase readoutNCT06005168: Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

Sponsor: University of Michigan. Phase: PHASE4. Conditions: Surgical Prophylaxis

full page →ctgov ↗

RECRUITINGphase readoutNCT05277168: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07506668: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Sponsor: Affiliated Hospital of Nantong University. Phase: PHASE1. Conditions: Relapsed/Refractory B-cell Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT03896568: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Malignant Glioma

full page →ctgov ↗

RECRUITINGphase readoutNCT07472959: Effect of Intraoperative Morphine on Postoperative Pain After CABG

Sponsor: Istanbul University - Cerrahpasa. Phase: PHASE4. Conditions: Cardiac Surgery Patient, Postoperative Pain, Pain After Surgery

full page →ctgov ↗

RECRUITINGphase readoutNCT07151859: Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration

Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Aesthetic Improvement of the Skin, Skin Hydration in Healthy Volunteers, Skin Elasticity, Skin Turgor, Subject Satisfaction

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07649759: Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity

Sponsor: Bern University of Applied Sciences. Phase: NA. Conditions: Obesity & Overweight, Emotional Eating Behaviour, Mindful Eating Intervention

full page →ctgov ↗

COMPLETEDphase readoutNCT07434362: Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Diabetic Retinopathy, Diabetes Mellitus, Retinal Microvascular Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07180862: A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗

RECRUITINGphase readoutNCT06477146: Milk Thistle Clinical Trial in Pediatric NAFLD

Sponsor: University Hospitals Cleveland Medical Center. Phase: PHASE2. Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01802346: Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

Sponsor: University of Southern California. Phase: NA. Conditions: Breast Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07662603: Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

Sponsor: Cairo University. Phase: NA. Conditions: Behcet Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07657988: Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)

Sponsor: Avant Health LLC. Phase: . Conditions: Actinic Keratosis (AK)

full page →ctgov ↗

RECRUITINGphase readoutNCT07370688: Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation

Sponsor: Erasmus Medical Center. Phase: PHASE4. Conditions: Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation), Cardiovascular Diseases

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07500961: Novel Bone Substitute (ALBO-OS) in Patients With Periodontal Disease or Who Need Alveolar Preservation

Sponsor: Albos d.o.o. Beograd. Phase: NA. Conditions: Periodontitis

full page →ctgov ↗

RECRUITINGphase readoutNCT07340242: Dentoskeletal Effects of 3D-Printed Fixed Twin Block Versus MARA Appliances in Management of Skeletal Class II

Sponsor: Mansoura University. Phase: NA. Conditions: Class II Malocclusion, Mandibular Deficiency

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06382142: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Triple-Negative Breast Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07564986: Relationship Between Serum Resistin Levels and Reduction in Visceral Fat in Patients Undergoing Sleeve Gastrectomy Due to Morbid Obesity

Sponsor: Sercan YUKSEL, MD. Phase: . Conditions: Morbid Obesity Requiring Bariatric Surgery

full page →ctgov ↗

COMPLETEDphase readoutNCT01538342: Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Psoriasis, Atopic Dermatitis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07619586: Lumbar Spinal Manipulation in Stroke

Sponsor: Bitlis Eren University. Phase: NA. Conditions: Stroke

full page →ctgov ↗

RECRUITINGphase readoutNCT06725173: Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Sponsor: University of Washington. Phase: . Conditions: Retinoblastoma Bilateral, Retinoblastoma Unilateral, Retinoblastoma, Extraocular, Retinoblastoma, Recurrent, Retinoblastoma

full page →ctgov ↗

RECRUITINGphase readoutNCT06363773: A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.

Sponsor: Elsan. Phase: NA. Conditions: Metastatic Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06431373: A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Sponsor: Priovant Therapeutics, Inc.. Phase: PHASE3. Conditions: Uveitis, Posterior, Uveitis, Intermediate, Uveitis

full page →ctgov ↗

COMPLETEDphase readoutNCT07031869: The Swedish Hockey League Hand and Wrist Injury Tracking Trial

Sponsor: Dalarna County Council, Sweden. Phase: . Conditions: Register, Injuries, Athletes, Hand Injuries, Wrist Injuries, Prevention

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07584369: Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study

Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: HIV -1 Infection, Methamphetamine Use

full page →ctgov ↗

← prev

page 97 of 102

Date TBD